Loss-of-function mutations in BMPR2 account for approximately 70% of genetic PAH, and reductions in BMPR2 protein have been reported in PAH patients with and without BMPR2 mutations, suggesting that this receptor likely contributes to disease pathogenesis independently of etiology. Here, BMPR2 is linked to pulmonary arterial hypertension.